(Reuters) – Well-known short-selling specialist Hindenburg Research published a critical report on Thursday on Chamath Palihapitiya-backed insurance firm Clover Health, sending the company’s shares down 5.4%.
Venture capital investor Palihapitiya, who held a 27% stake in Clover Health as of Jan. 7, was among the big financial names to support last week’s GameStop (NYSE:) buying frenzy against institutional short-sellers, saying early in the slugfest that he had bought into the video game retailer.
The report, whose title called Clover Health a “broken business”, risks reheating the battle between hedge fund short-sellers and investors over a number of U.S. companies.
Clover Health did not immediately respond to a Reuters request for comment.
Hindenburg said in the report that it had no investment position in Clover Health.
Citron, another of the financial world’s famous short-selling research houses, said last week it would not be publishing reports recommending shorts any longer.
Clover, which sells Medicare-backed insurance plans, went public through a $3.7 billion deal with a special purpose acquisition company (SPAC) backed by Palihapitiya. Its other investors had included Alphabet (NASDAQ:) Inc and Sequoia Capital.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Be the first to comment